TALO-ZANAMIVIR

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C12H20N4O7
Molecular Weight	332.3098
Optical Activity	UNSPECIFIED
Defined Stereocenters	5 / 5
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(=O)N[C@@H]1[C@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O

InChI

InChIKey=ARAIBEBZBOPLMB-PKGQWCBFSA-N

InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6-,8-,9-,10-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C12H20N4O7
Molecular Weight	332.3098
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	5 / 5
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8808739

Talo-Zanamivir is inactive enantiomer of Zanamivir, a medication used to treat and prevent influenza caused by influenza A and B viruses. Talo-Zanamivir is used as internal standard for Zanamivir analytical studies.

Originator

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Unknown 2596

PubMed

Title	Date	PubMed
A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase.	1996-06	8808739

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Tue Apr 01 16:22:56 GMT 2025` Edited by `admin` on `Tue Apr 01 16:22:56 GMT 2025`
Record UNII	4T35I32653
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TALO-ZANAMIVIR

Common Name

English

ZANAMIVIR HYDRATE IMPURITY H [EP IMPURITY]

Preferred Name

English

(2R,3R,4R)-3-(ACETYLAMINO)-4-CARBAMIMIDOYLAMINO-2-((1R,2R)-1,2,3-TRIHYDROXYPROPYL)-3,4-DIHYDRO-2H-PYRAN-6-CARBOXYLIC ACID

Systematic Name

English

D-GLYCERO-D-TALO-NON-2-ENONIC ACID, 5-(ACETYLAMINO)-4-((AMINOIMINOMETHYL)AMINO)-2,6-ANHYDRO-3,4,5-TRIDEOXY-

Systematic Name

English

Code System Code Type Description

CAS

179531-57-8

Created by admin on Tue Apr 01 16:22:56 GMT 2025 , Edited by admin on Tue Apr 01 16:22:56 GMT 2025

PRIMARY

PUBCHEM

58974096

Created by admin on Tue Apr 01 16:22:56 GMT 2025 , Edited by admin on Tue Apr 01 16:22:56 GMT 2025

PRIMARY

FDA UNII

4T35I32653

Created by admin on Tue Apr 01 16:22:56 GMT 2025 , Edited by admin on Tue Apr 01 16:22:56 GMT 2025

PRIMARY

Related Record Type Details


					9E25RDB1Q0

ZANAMIVIR HYDRATE

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:

Details

SMILES

InChI

DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/8808739

Originator

Approval Year

Conditions

PubMed

Patents

Sample Use Guides

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8808739